Navigation Links
Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
Date:6/26/2008

s results. There can be no assurance that the actual results or developments anticipated by Vanda will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, Vanda. Therefore, no assurance can be given that the outcomes stated in such forward-looking statements and estimates will be achieved.

All written and verbal forward-looking statements attributable to Vanda or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements contained or referred to herein. Vanda cautions investors not to rely too heavily on the forward-looking statements Vanda makes or that are made on its behalf. The information in this release is provided only as of the date of this release, and Vanda undertakes no obligation, and specifically declines any obligation, to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

References:

1. Doghramji K. Melatonin and its receptors: a new class of

sleep-promoting agents. J Clin Sleep Med. 2007;3:S17-S23.

2. Rajput V, Bromley SM. Chronic insomnia: a practical review. AAFP.

1999;60:1431-1438.

3. National Sleep Foundation. Most Common Sleep Problems in Women.

Available at:

http://www.sleepfoundation.org/site/c.huIXKjM0IxF/b.2421125/

k.6662/Most_Common_Sleep_Problems_in_Women.htm. Accessed on

June 18, 2008.

4. Centers for Disease Control and Prevention. Perceived Insufficient

Rest or Sleep - Four States, 2006. MMWR. 2008;57:200-203.

5. National Institutes of Health. NIH State-of-the-Science Conference

Statement on Manifestations and Management of Chronic Insomnia in

Adults. Available at:


SOURCE Vanda Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 2014 /PRNewswire-iReach/ -- CountryFocus: Healthcare, Regulatory and Reimbursement ... (Photo - http://photos.prnewswire.com/prnh/20140828/140879 ) ... Reimbursement Landscape Poland " an essential source of ... healthcare market and provides insights into the demographic, ... the report provides valuable insights into the trends ...
(Date:8/28/2014)... , Aug. 28, 2014 Tianyin ... ), a pharmaceutical company that specializes in patented ... and active pharmaceutical ingredients (API) today updates the ... Qionglai Facility (QLF). The Company ... (GMP) dataset for China Food & Drug Administration,s ...
(Date:8/28/2014)... LAKE CITY , Aug. 28, 2014 /PRNewswire-iReach/ -- ... 2000 by service academy graduates, has published a ... concentrated, three-day Leadership Excellence Course . In September ... Leadership Excellence Course to Albuquerque , ... Tucson . Photo - http://photos.prnewswire.com/prnh/20140828/140814 ...
Breaking Medicine Technology:Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 2Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 3Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 4Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 5TPI Submits Dataset for GMP Inspection at Qionglai Facility (QLF) 2Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 2Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 3Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 4Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 5
... Genoptix, Inc. (Nasdaq: GXDX ) announced today ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... tender offer by Novartis to purchase all outstanding shares of ... The termination of the HSR Act waiting period satisfies one ...
... LA JOLLA, Calif., Feb. 7, 2011 DermTech ... genomic medicine to dermatologists, today announced that the ... melanoma have been published in the British Journal ... EGIR™ technology (Epidermal Genetic Information Retrieval) that non-invasively ...
Cached Medicine Technology:FTC Grants Early Termination of Waiting Period Under Hart-Scott-Rodino Act 2Data on DermTech's Non-invasive Test for Melanoma Are Published in the British Journal of Dermatology 2Data on DermTech's Non-invasive Test for Melanoma Are Published in the British Journal of Dermatology 3Data on DermTech's Non-invasive Test for Melanoma Are Published in the British Journal of Dermatology 4
(Date:8/28/2014)... 29, 2014 Doctors Frank DellaCroce and ... Breast Surgery (CRBS) and the St. Charles ... to announce that board certified surgeon Dr. Craig Ashley ... surgeons devoted to reconstructive breast surgery. Blum will work ... Sullivan, Christopher Trahan, and M. Whitten Wise. , “We ...
(Date:8/28/2014)... August 29, 2014 Involution ... some of the healthcare industry's most pressing problems, ... radically rethink health. Involution Studios' creative team ... creating software solutions for clients including AstraZeneca, 3M ... As part of the studio's philosophy to change ...
(Date:8/28/2014)... Alexandria, VA (PRWEB) August 28, 2014 ... Foundation (Meso Foundation) is able to accept donations in ... give. The Bitcoin donation page can be found at ... businesses are accepting Bitcoin as a form of payment, ... the same,” said Meso Foundation’s chief executive officer, Melinda ...
(Date:8/28/2014)... Recently, Skmen.com, one of the most popular suppliers ... collection of long sleeve sweater dresses and ... company’s newly unveiled sweater outfits are available at discounted ... a matter of fact, Skmen.com’s fashionable and quality items ... years. The company’s experienced tailors are striving to make ...
(Date:8/28/2014)... Dallas, TX (PRWEB) August 29, 2014 ... and in-depth study on the current state of the ... provides a basic overview of the industry, including definitions, ... Chinese domestic market analysis are provided with a focus ... market. A comparison between the international and Chinese situation ...
Breaking Medicine News(10 mins):Health News:New Plastic Surgeon Joins Center For Restorative Breast Surgery 2Health News:Top Three Open Source Design Concepts that Rethink Health from Involution Studios 2Health News:Top Three Open Source Design Concepts that Rethink Health from Involution Studios 3Health News:Cancer Research Funding Organization Now Accepts Bitcoin Donations 2Health News:Skmen.com: Bestselling Long Sleeve Sweater Dresses Are Offered Online Now 2Health News:Global Oscilloscope Industry (North America, Europe, Asia, and ROW) Forecast Report 2020 Now Available at ReportsnReports.com 2Health News:Global Oscilloscope Industry (North America, Europe, Asia, and ROW) Forecast Report 2020 Now Available at ReportsnReports.com 3
... ... ... ... WHEATON, Ill. , March 17 Life Care Services LLC (LCS) of Des Moines, Iowa , recently announced the acquisition of Wyndemere Senior Living Community in ...
... million Americans don,t know they have type 2, experts say ... of Americans have prediabetes and are at high risk for ... "Look around you. We are surrounded by [diabetes] risk," Christine ... American Diabetes Association, said in a news release. She said ...
... powers of standard risk model , WEDNESDAY, March 17 (HealthDay ... risk-assessment model for breast cancer won,t do much to help ... study shows. , Assessing a woman,s breast cancer risk remains ... relied on what,s known as the "Gail model," which asks ...
... March 17 Recent laboratory experiments which seek to recreate the formation of the first living ... occurred on earth and on other planets, biologist Jack Szostak and chemist Brian Paegel ... the Scripps Research Institute. , ... ...
... March 17 Massage Prep, the massage industry,s ... study program for the NCETM , NCETMB ... muscle tutorials, 25 interactive study guides, and 7 skeletal tutorials, ... narration for auditory learners, further cement the Massage Prep guarantee ...
... CITYTreating virulent influenza, sepsis, and other potentially deadly infections long ... bacteria. But new research from the University of Utah and ... inflammatory response to infection may help save more lives. ... Translational Medicine , researchers led by U of U cardiologist ...
Cached Medicine News:Health News:Wyndemere Senior Living Community Acquired by Life Care Services 2Health News:Wyndemere Senior Living Community Acquired by Life Care Services 3Health News:Wyndemere Senior Living Community Acquired by Life Care Services 4Health News:Online, Phone Tests Assess Diabetes Risk 2Health News:Newer Genetic Info Adds Little to Predicting Breast Cancer 2Health News:Newer Genetic Info Adds Little to Predicting Breast Cancer 3Health News:Top Scientists Explore the Origin of Life in Annual Lasker Lecture at Scripps Research Institute Florida Campus 2Health News:Top Scientists Explore the Origin of Life in Annual Lasker Lecture at Scripps Research Institute Florida Campus 3Health News:Top Scientists Explore the Origin of Life in Annual Lasker Lecture at Scripps Research Institute Florida Campus 4Health News:Top Scientists Explore the Origin of Life in Annual Lasker Lecture at Scripps Research Institute Florida Campus 5Health News:Massage Prep(TM) Announces New Interactive Tutorials for NCETM, NCETMB and MBLEx 2Health News:Massage Prep(TM) Announces New Interactive Tutorials for NCETM, NCETMB and MBLEx 3Health News:Massage Prep(TM) Announces New Interactive Tutorials for NCETM, NCETMB and MBLEx 4Health News:Massage Prep(TM) Announces New Interactive Tutorials for NCETM, NCETMB and MBLEx 5Health News:Massage Prep(TM) Announces New Interactive Tutorials for NCETM, NCETMB and MBLEx 6Health News:Targeting blood vessels, immune system may offer way to stop infection-caused inflammation 2Health News:Targeting blood vessels, immune system may offer way to stop infection-caused inflammation 3
The DePuy ACE Titanium Active Compression Plate offers ingenuity in the art of fracture management....
Long Handled Trephine...
... control you've come to demand in BD ... BD K-4000 microkeratome is built upon. , ... monitoring. The front panel on the new ... and bright visual feedback., ,The BD K-4000 ...
... third-generation allergy test , 3gAllergy is a ... provides quantitative determination of allergen-specific IgE at ... and lot-to-lot reproducibility. The assay delivers reliable ... you identify, monitor and manage patients with ...
Medicine Products: